BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31811131)

  • 1. Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution.
    Karacosta LG; Anchang B; Ignatiadis N; Kimmey SC; Benson JA; Shrager JB; Tibshirani R; Bendall SC; Plevritis SK
    Nat Commun; 2019 Dec; 10(1):5587. PubMed ID: 31811131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperative signaling between oncostatin M, hepatocyte growth factor and transforming growth factor-β enhances epithelial to mesenchymal transition in lung and pancreatic tumor models.
    Argast GM; Mercado P; Mulford IJ; O'Connor M; Keane DM; Shaaban S; Epstein DM; Pachter JA; Kan JL
    Cells Tissues Organs; 2011; 193(1-2):114-32. PubMed ID: 21041998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
    Tan EJ; Olsson AK; Moustakas A
    Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct regulation of transforming growth factor β-induced epithelial-mesenchymal transition by the protein phosphatase activity of unphosphorylated PTEN in lung cancer cells.
    Kusunose M; Hashimoto N; Kimura M; Ogata R; Aoyama D; Sakamoto K; Miyazaki S; Ando A; Omote N; Imaizumi K; Kawabe T; Hasegawa Y
    Cancer Sci; 2015 Dec; 106(12):1693-704. PubMed ID: 26450531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGFβ-induced epithelial-to-mesenchymal transition.
    Du L; Yamamoto S; Burnette BL; Huang D; Gao K; Jamshidi N; Kuo MD
    Cancer Med; 2016 Aug; 5(8):1962-72. PubMed ID: 27318801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGFβ selects for pro-stemness over pro-invasive phenotypes during cancer cell epithelial-mesenchymal transition.
    Tsubakihara Y; Ohata Y; Okita Y; Younis S; Eriksson J; Sellin ME; Ren J; Ten Dijke P; Miyazono K; Hikita A; Imamura T; Kato M; Heldin CH; Moustakas A
    Mol Oncol; 2022 Jun; 16(12):2330-2354. PubMed ID: 35348275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
    Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
    Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotyping EMT and MET cellular states in lung cancer patient liquid biopsies at a personalized level using mass cytometry.
    Karacosta LG; Pancirer D; Preiss JS; Benson JA; Trope W; Shrager JB; Sung AW; Neal JW; Bendall SC; Wakelee H; Plevritis SK
    Sci Rep; 2023 Dec; 13(1):21781. PubMed ID: 38065965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-to-mesenchymal transition proceeds through directional destabilization of multidimensional attractor.
    Wang W; Poe D; Yang Y; Hyatt T; Xing J
    Elife; 2022 Feb; 11():. PubMed ID: 35188459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states.
    Toneff MJ; Sreekumar A; Tinnirello A; Hollander PD; Habib S; Li S; Ellis MJ; Xin L; Mani SA; Rosen JM
    BMC Biol; 2016 Jun; 14():47. PubMed ID: 27317311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial-mesenchymal transition (EMT).
    Serrano I; McDonald PC; Lock FE; Dedhar S
    Oncogene; 2013 Jan; 32(1):50-60. PubMed ID: 22310280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
    Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
    Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial to Mesenchymal Transition in Human Mesothelial Cells Exposed to Asbestos Fibers: Role of TGF-β as Mediator of Malignant Mesothelioma Development or Metastasis via EMT Event.
    Turini S; Bergandi L; Gazzano E; Prato M; Aldieri E
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.
    Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG;
    Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of mesenchymal hybrid epithelial state and phenotypic transitions in EMT and MET processes of cancer cells.
    He P; Qiu K; Jia Y
    Sci Rep; 2018 Sep; 8(1):14323. PubMed ID: 30254295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Tyrosine-Phosphorylated Proteins Upregulated during Epithelial-Mesenchymal Transition Induced with TGF-β.
    Okayama A; Miyagi Y; Oshita F; Ito H; Nakayama H; Nishi M; Kurata Y; Kimura Y; Ryo A; Hirano H
    J Proteome Res; 2015 Oct; 14(10):4127-36. PubMed ID: 26216473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells.
    Schlegel NC; von Planta A; Widmer DS; Dummer R; Christofori G
    Exp Dermatol; 2015 Jan; 24(1):22-8. PubMed ID: 25363503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
    Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Cell-Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of Lung Cancer Cells While Avoiding Hybrid States.
    Kim N; Hwang CY; Kim T; Kim H; Cho KH
    Cancer Res; 2023 Mar; 83(6):956-970. PubMed ID: 36710400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
    Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.